GSA Capital Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,644
| Closed | -$117K | – | 2092 |
|
|
2025
Q1 | $117K | Buy |
+11,644
| New | +$117K | 0.01% | 1478 |
|
|
2024
Q4 | – | Sell |
-32,733
| Closed | -$378K | – | 1968 |
|
|
2024
Q3 | $378K | Sell |
32,733
-2,180
| -6% | -$25.2K | 0.03% | 1106 |
|
|
2024
Q2 | $369K | Sell |
34,913
-15,076
| -30% | -$159K | 0.03% | 1155 |
|
|
2024
Q1 | $527K | Buy |
+49,989
| New | +$527K | 0.04% | 851 |
|
|
2023
Q3 | – | Sell |
-48,215
| Closed | -$486K | – | 1840 |
|
|
2023
Q2 | $486K | Sell |
48,215
-438
| -0.9% | -$4.42K | 0.05% | 760 |
|
|
2023
Q1 | $359K | Buy |
48,653
+18,824
| +63% | +$139K | 0.04% | 917 |
|
|
2022
Q4 | $238K | Buy |
+29,829
| New | +$238K | 0.03% | 1079 |
|